Literature DB >> 12177005

Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter.

Scott R Eberhardy1, Peggy J Farnham.   

Abstract

The c-Myc protein is up-regulated in many different types of cancer, suggesting that a detailed understanding of Myc function is an important goal. Our previous studies have focused on determining the mechanism by which Myc activates transcription using the target gene cad as an experimental model. Previously, we found that Myc activates cad transcription at a post-RNA polymerase II recruitment step and that the Myc transactivation domain interacts with a number of cdk-cyclin complexes. We now extend these studies to determine the role of these cyclin-cdk complexes in Myc-mediated transactivation. We have found that cyclin T1 binding to Myc localizes to the highly conserved Myc Box I, whereas cdk8 binding localizes to the amino-terminal 41 amino acids of the Myc transactivation domain. We showed that recruitment of cdk8 is sufficient for activation of a synthetic promoter construct. In contrast, the ability of Myc to activate transcription of the cad promoter correlates with binding of cyclin T1. Furthermore, recruitment of cyclin T1 to the cad promoter via a Gal4 fusion protein or through protein-protein interaction with the HIV-1 Tat protein can also activate cad transcription. These results suggest that Myc activates transcription by stimulating elongation and that P-TEFb is a key mediator of this process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12177005     DOI: 10.1074/jbc.M207441200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  115 in total

1.  Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins.

Authors:  Caroline Bouchard; Judith Marquardt; Alexandra Brás; René H Medema; Martin Eilers
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

Review 2.  MYC: connecting selective transcriptional control to global RNA production.

Authors:  Theresia R Kress; Arianna Sabò; Bruno Amati
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

Review 3.  The mediator of RNA polymerase II.

Authors:  Erik Blazek; Gerhard Mittler; Michael Meisterernst
Journal:  Chromosoma       Date:  2005-02-03       Impact factor: 4.316

4.  Runx1 binds positive transcription elongation factor b and represses transcriptional elongation by RNA polymerase II: possible mechanism of CD4 silencing.

Authors:  Huimin Jiang; Fan Zhang; Takeshi Kurosu; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

Review 5.  OTX2 expression contributes to proliferation and progression in Myc-amplified medulloblastoma.

Authors:  Yining Lu; Collin M Labak; Neha Jain; Ian J Purvis; Maheedhara R Guda; Sarah E Bach; Andrew J Tsung; Swapna Asuthkar; Kiran K Velpula
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

Review 6.  Role of helix-loop-helix proteins during differentiation of erythroid cells.

Authors:  Archana Anantharaman; I-Ju Lin; Joeva Barrow; Shermi Y Liang; Jude Masannat; John Strouboulis; Suming Huang; Jörg Bungert
Journal:  Mol Cell Biol       Date:  2011-01-31       Impact factor: 4.272

7.  The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60.

Authors:  Jagruti H Patel; Yanping Du; Penny G Ard; Charles Phillips; Beth Carella; Chi-Ju Chen; Carrie Rakowski; Chandrima Chatterjee; Paul M Lieberman; William S Lane; Gerd A Blobel; Steven B McMahon
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

8.  Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes.

Authors:  Yoichi Sunagawa; Tatsuya Morimoto; Tomohide Takaya; Shinji Kaichi; Hiromichi Wada; Teruhisa Kawamura; Masatoshi Fujita; Akira Shimatsu; Toru Kita; Koji Hasegawa
Journal:  J Biol Chem       Date:  2010-01-17       Impact factor: 5.157

9.  Effect of mimetic CDK9 inhibitors on HIV-1-activated transcription.

Authors:  Rachel Van Duyne; Irene Guendel; Elizabeth Jaworski; Gavin Sampey; Zachary Klase; Hao Chen; Chen Zeng; Dmytro Kovalskyy; Mahmoud H El Kouni; Benjamin Lepene; Alexis Patanarut; Sergei Nekhai; David H Price; Fatah Kashanchi
Journal:  J Mol Biol       Date:  2012-12-13       Impact factor: 5.469

10.  Progranulin (granulin/epithelin precursor) and its constituent granulin repeats repress transcription from cellular promoters.

Authors:  Mainul Hoque; Michael B Mathews; Tsafi Pe'ery
Journal:  J Cell Physiol       Date:  2010-04       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.